TelyRx Holdings Inc.TELY.TO
Health Care · Health Care Equipment & Services · TSX · United States · telyrx.com
Technology-enabled digital pharmacy platform headquartered in Clearwater, Florida, providing access to over 450 FDA-approved medications across 48 U.S. states and territories by connecting patients with licensed providers online and fulfilling prescriptions through licensed retail pharmacies.
Key ratios
FCF / Sales
-3.2%2025
2024
-32.2%2023
-9277.8%
Net margin
-18.2%TTM
2025
-12.6%2024
-141.4%
ROA
-33.4%TTM
2025
-33.4%2024
-24.7%
Revenue growth
350.3%2025
2024
35207.4%
Recent news
TelyRx Announces Second Quarter 2026 Financial Results
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
TelyRx to Host Second Quarter 2026 Financial Results Conference Call on Monday, August 10, 2026 at 8:30 am ET
TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare
Track TELY.TO in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer